Front Matter
Preliminary Material
PART I: How to Evaluate a Potentially Infected Patient
I.1 Is the Patient Infected?
I.2 Clinically Significant Microorganism Basics
I.3 Does The Patient Have Any Healthcare-Associated Risk Factors?
PART II: What Is the Suspected Source of Infection and What Organisms Are Typically Associated with Infection at This Site?
II.1 Bacterial Meningitis
II.2 Candidiasis
II.3 Catheter-Related Bloodstream Infections
II.4 Clostridium Difficile Infection
II.5 Infective Endocarditis
II.6 Intra-Abdominal Infections
II.7 Neutropenic Fever
II.8 Otitis Media
II.9 Pharyngitis
II.10 Pneumonia
II.11 Rhinosinusitis
II.12 Sepsis and Septic Shock in Adults
II.13 Skin and Soft Tissue Infections and Osteomyelitis
II.14 Urinary Tract Infections and Prostatitis
PART III: What Anti-Infectives Provide Adequate Coverage for the Suspected Infection?
III.1 Antifungals
III.2 Antimicrobials
III.3 Antivirals
PART IV: What Patient- or Disease State-Specific Factors Affect Your Decision?
IV.1 β-Lactam Allergies and Cross-Reactivity
IV.2 Adult Renal Dosing Chart
IV.3 Antimicrobial Pharmacodynamics
IV.4 Antimicrobial Pharmacokinetics
PART V: What Antimicrobial Stewardship Interventions Can Be Made on Reassessment and What Needs to Be Monitored?
V.1 Antimicrobial Stewardship Basics—Where to Start And How to Maintain
V.3 Rapid Diagnostic Tests for Antimicrobial Stewardship
V.4 Comparative Estimated Drug Acquisition Cost per Dose
Back Matter
Appendix A: ASHP Statement on the Pharmacist's Role in Antimicrobial Stewardship and Infection Prevention and Control
Index of Drugs

V.2 Top 10 Clinical Antimicrobial Stewardship Interventions/Opportunities

in The Pharmacist's Guide to Antimicrobial Therapy and Stewardship
DOI:
https://doi.org/10.37573/9781585285204.026
Restricted access